Alexandra Kautzky-Willer Selected Research

Gestational Diabetes (Gestational Diabetes Mellitus)

12/2021	Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status.
11/2021	Model-Based Assessment of Hepatic and Extrahepatic Insulin Clearance from Short Insulin-Modified IVGTT in Women with a History of Gestational Diabetes.
8/2021	Correction: Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care.
8/2021	Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care.
1/2021	RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy.
1/2021	Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women-a secondary analysis of the DALI study.
7/2020	Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy.
1/2020	Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus.
1/2020	Insulin clearance is altered in women with a history of gestational diabetes progressing to type 2 diabetes.
1/2020	The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandra Kautzky-Willer Research Topics

Disease

69	Insulin Resistance 01/2022 - 11/2002
69	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2021 - 02/2003
41	Type 2 Diabetes Mellitus (MODY) 04/2022 - 01/2002
23	Obesity 04/2022 - 07/2004
19	Diabetes Mellitus 01/2022 - 08/2012
12	Glucose Intolerance 01/2021 - 01/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2008
10	Hyperglycemia 11/2020 - 07/2011
9	Prediabetic State (Prediabetes) 01/2022 - 01/2004
8	Fatty Liver 01/2022 - 04/2011
8	Weight Loss (Weight Reduction) 01/2021 - 02/2010
8	Birth Weight (Birth Weights) 01/2020 - 01/2003
7	Overweight 10/2021 - 01/2007
7	Body Weight (Weight, Body) 01/2021 - 07/2003
7	Inflammation (Inflammations) 01/2021 - 07/2004
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2017 - 01/2003
6	Osteoporosis 12/2021 - 04/2012
5	Neoplasms (Cancer) 01/2022 - 12/2013
5	Myocardial Infarction 01/2022 - 04/2016
5	Hypoglycemia (Reactive Hypoglycemia) 05/2019 - 01/2003
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2010
5	Stillbirth 07/2018 - 01/2003
5	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 01/2003
4	Stroke (Strokes) 01/2022 - 04/2016
4	Vascular Diseases (Vascular Disease) 04/2016 - 06/2011
3	COVID-19 01/2022 - 01/2021
3	Weight Gain 01/2022 - 02/2013
3	Acute Coronary Syndrome 01/2022 - 02/2016
3	Morbid Obesity 01/2022 - 06/2014
3	Infections 10/2021 - 01/2016
3	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2020 - 01/2016
3	Fetal Diseases (Embryopathy) 05/2019 - 12/2012
3	Ketosis 05/2019 - 12/2012
3	Erectile Dysfunction 05/2019 - 12/2012
3	Gestational Weight Gain 01/2019 - 07/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2013 - 11/2002
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 10/2014
2	Pain (Aches) 01/2021 - 03/2016
2	Acromegaly 12/2020 - 11/2014
2	Hypothyroidism 12/2020 - 12/2008
2	Chronic Disease (Chronic Diseases) 09/2020 - 01/2020
2	Malnutrition (Nutritional Deficiencies) 01/2020 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2020 - 05/2014

Drug/Important Bio-Agent (IBA)

95	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2002
44	Insulin (Novolin)FDA Link 12/2021 - 02/2003
24	LipidsIBA 01/2021 - 02/2003
12	Vitamin D FDA LinkGeneric 01/2021 - 07/2013
10	C-PeptideIBA 11/2020 - 02/2010
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 06/2012
8	LeptinIBA 01/2020 - 07/2004
7	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2013
7	C-Reactive ProteinIBA 01/2021 - 07/2004
7	AndrogensIBA 10/2020 - 12/2012
7	Triglycerides (Triacylglycerol)IBA 05/2017 - 04/2011
6	Testosterone (Sustanon)FDA Link 01/2022 - 04/2011
6	Biological ProductsIBA 01/2022 - 01/2017
6	CholesterolIBA 01/2021 - 01/2002
6	AdiponectinIBA 01/2018 - 07/2004
5	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021 - 04/2012
5	HDL LipoproteinsIBA 03/2019 - 04/2011
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 08/2005
4	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 06/2012
4	ORALIT (ORS)IBA 09/2021 - 12/2019
4	Hormones (Hormone)IBA 01/2021 - 06/2014
4	Growth Differentiation Factor 15IBA 01/2021 - 01/2012
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2019 - 04/2011
4	AdipokinesIBA 01/2018 - 07/2004
4	CreatinineIBA 02/2016 - 06/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2017
3	HDL CholesterolIBA 01/2021 - 07/2011
3	Adenosine Triphosphate (ATP)IBA 12/2020 - 01/2011
3	EnzymesIBA 09/2020 - 01/2012
3	alpha-2-HS-GlycoproteinIBA 12/2012 - 01/2012
3	OsteocalcinIBA 01/2012 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 01/2010 - 12/2004
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2021 - 01/2020
2	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2021 - 11/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 07/2004
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2014
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2021
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 03/2011
2	MineralsIBA 01/2021 - 05/2019
2	SodiumIBA 10/2020 - 01/2020
2	Melatonin Receptors (Melatonin Receptor)IBA 01/2020 - 11/2018
2	oxidized low density lipoproteinIBA 01/2020 - 03/2019
2	hydroxide ionIBA 01/2020 - 12/2008

Therapy/Procedure

27	Therapeutics 12/2021 - 12/2008
10	Bariatric Surgery 01/2022 - 06/2008
10	Glycemic Control 05/2019 - 12/2010
4	Percutaneous Coronary Intervention 01/2022 - 02/2016
4	Drug Therapy (Chemotherapy) 09/2021 - 04/2012
4	Aftercare (After-Treatment) 08/2021 - 10/2020
3	Length of Stay 09/2021 - 03/2018
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 02/2010
2	Precision Medicine 12/2020 - 11/2020